At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
0.13% Benzalkonium Chloride +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin
In Brief
A clinical study evaluating 0.13% Benzalkonium Chloride, SLS Solution, and 2 other interventions for Wound Healing. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate the irritation potential of benzalkonium chloride disinfectant spray when placed in contact with normal human skin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound Healing
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
Primary CompletionFeb 2012
First PostedJan 2013
TodayJul 2026
First PostedJan 8, 2013
Enrollment StartFeb 1, 2012
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 13.5 years ago
Interventions
0.13% Benzalkonium Chloridedrug
Finn Chamber filled with benzalkonium chloride (0.13%) disinfectant spray water solution
SLS Solutiondrug
Finn Chamber filled with SLS (0.3% w/v) water solution
Normal Saline Waterdrug
Finn Chamber filled with Normal Saline water (0.9% w/v)
Empty Finn Chamberother
Empty Finn Chamber